title: Successful treatment with adalimumab in a patient with coexisting Behçet's disease and ankylosing spondylitis.
abstract: The objective is to report a patient with concomitant ankylosing spondylitis (AS) and Behçet's disease (BD) successfully treated with adalimumab. A 44-year-old male diagnosed as AS applied to our outpatient clinic with complaints of morning stiffness, pain and limitation of motion at spine, concurrence of oral and genital ulcerated lesions. He was on sulfasalazine together with different NSAIDs for the past 1 year. According to the criteria of International Study Group, he was diagnosed as BD. The patient was considered as refractory to current treatment and adalimumab treatment was started. During follow-up, not only AS was in remission, but also no new oral and genital ulcerations appeared. There were no complications related to the use of anti-TNFalpha therapy. In our case it was observed that anti-TNFalpha therapy, specifically adalimumab, was effective for symptoms of both AS and BD.
authors.affiliation: Medicine Faculty, Pamukkale University, Denizli, Turkey.
authors.forename: Necmettin
authors.initials: N
authors.lastname: Yildiz
authors.forename: Hakan
authors.initials: H
authors.lastname: Alkan
authors.forename: Fusun
authors.initials: F
authors.lastname: Ardic
authors.forename: Oya
authors.initials: O
authors.lastname: Topuz
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D008297:Male; D013167:Spondylitis, Ankylosing / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab
references.citation: Rev Rhum Engl Ed. 1995 Apr;62(4):295-9
references.pmid: 7606426
references.citation: Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii2-25
references.pmid: 19022808
references.citation: Ann Rheum Dis. 2004 Jun;63(6):744-5
references.pmid: 15140785
references.citation: Eye (Lond). 2007 Jun;21(6):824-5
references.pmid: 16601736
references.citation: J Clin Rheumatol. 2006 Dec;12(6):282-6
references.pmid: 17149058
references.citation: Ann Rheum Dis. 2001 Jun;60(6):637
references.pmid: 11350856
references.citation: Curr Opin Rheumatol. 1996 Jul;8(4):275-87
references.pmid: 8864578
references.citation: Ann Rheum Dis. 1981 Dec;40(6):558-9
references.pmid: 7332375
references.citation: Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii51-3
references.pmid: 12379622
references.citation: Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S99-102
references.pmid: 17949561
references.citation: Curr Opin Rheumatol. 1994 Jan;6(1):39-43
references.pmid: 8031678
references.citation: Rheumatology (Oxford). 2007 May;46(5):736-41
references.pmid: 17403712
references.citation: Ann Rheum Dis. 2007 Apr;66(4):565-6
references.pmid: 17124248
references.citation: Eur J Ophthalmol. 1995 Jul-Sep;5(3):192-4
references.pmid: 8845689
references.citation: Rheumatol Int. 2000;19(5):195-8
references.pmid: 10984138
references.citation: J Rheumatol. 1997 Jan;24(1):128-32
references.pmid: 9002023
references.citation: Clin Rheumatol. 1996 Nov;15(6):619-20
references.pmid: 8973876
references.citation: J Rheumatol. 2005 Jan;32(1):98-105
references.pmid: 15630733
references.citation: Arthritis Rheum. 1998 Apr;41(4):694-700
references.pmid: 9550479
references.citation: Ann Rheum Dis. 1988 Sep;47(9):780-3
references.pmid: 3178318
references.citation: Br J Rheumatol. 1992 May;31(5):299-308
references.pmid: 1581771
references.citation: Arthritis Rheum. 1995 Apr;38(4):499-505
references.pmid: 7718003
references.citation: Arthritis Rheum. 1984 Apr;27(4):361-8
references.pmid: 6231933